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ABSTRACT 
Objective: To describe the clinical characteristics of pleural 
empyema in children caused by Streptococcus pneumoniae 
nonsusceptible to penicillin and compare their clinical outcome 
with pleural empyemas caused by penicillin-susceptible organ- 
isms. 
Methods: Records of 109 children with complicated pleural 
effusions between January 1996 and December 1998 were 
retrospectively reviewed. 
Results: Pathogens were recovered in 45 of these cases. Strep- 
tococcus pneumoniae represented 71% of the isolates, with 20 
(62%) and 12 (38%) of the strains proving susceptible and non- 
susceptible to penicillin, respectively. The average age for chil- 
dren with penicillin-nonsusceptible infections was 18.3 months 
compared with an average age of 40.9 months for those with 
penicillin-susceptible infections (P = 0.03). Previous antibiotic 
treatment was more frequent in children with penicillin-non- 
susceptible organisms (P = 0.05). No significant differences 
were found between the two groups for gender, underlying dis- 
eases, duration of fever and tachypnea, need of surgical treat- 
ment, bacteremia incidence, mean duration of therapy, or length 
of hospital stay. 
Conclusions: Pleural empyemas caused by penicillin-nonsus- 
ceptible S. pneumoniae appear to be associated with younger 
age and previous antibiotic treatment. By contrast, the out- 
come was not influenced by the penicillin susceptibility of the 
pneumococcus strains. 
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Pleural empyema is a rare complication of pneumonia in 
children,‘,* with Streptococcus pneumoniae being the 
major pathogen associated with this infection.‘-’ 
During the past decade, penicillin-nonsusceptible iso- 
lates of S. pneumoniae have become frequent, compli- 
cating the empirical choice of therapy for pneumonia 
and pleural empyemas. - 8 ‘” However, the actual effect of 
this situation in the clinical setting remains to be clarified 
and data on pediatric patients are scarce.8-10 Therefore, 
a retrospective study was undertaken to assess the out- 
come and clinical features in children with pleural empye- 
mas caused by penicillin-nonsusceptible (PCN-N) and 
penicillin-susceptible (PCN-S) S. pneumoniae. 
MATERIAL AND METHODS 
All records of children with a diagnosis of complicated 
pleural effusions or empyema occurring between January 
I996 and December 1998, at the Hospital de Pediatria 
Profesor Dr. Juan F? Garrahan, Buenos Aires, Argentina 
were reviewed. 
Pleural empyema was defined by either the presence 
of pus in the pleural space; or the isolation of respiratory 
pathogen from pleural fluid; or a pleural fluid with pH of 
7.2 or less, glucose 40 mg% or less, white blood cell 
(WBC) count 10,000/mm3 or higher, lactate dehydroge- 
nase 1.000 U/L or more, and a positive blood culture. 
Patients infected with Spneumoniae were grouped 
into categories of either PCN-N or PCN-S. Cultures and 
identification were performed by the standard proce- 
dures. Antimicrobial susceptibility was determined by 
using the screening test with a l-Kg oxacillin disk.” In 
addition, minimum inhibitory concentrations (MICs) for 
penicillin and cefiriaxone were determined by E-test (AB 
Biodisk, Solna, Sweden) and the broth macrodilution 
method, following the guidelines of the manufacturer and 
the National Committee for Clinical Laboratory Standards, 
respectively.‘* Although MICs determined by the dilution 
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Table 1. Comparative Features of 32 Children with Pleural Empyema Caused by Penicillin-nonsusceptible 
and Penicillin-susceptible Streptococcus pneurnoniee 
Characteristic PCN-S (n = 20) PCN-N (n= 12) 
Age* (range) (mo) 40.9 5 36.8 (2-l 56) 18.3 +- 12.1 (8-54)+ 
Male patients n (%) 13 (65) 4 (33) 
Underlying disease n (%) 2 (10) l(8) 
Previous antibiotic treatment n (%) l(5) 4 (33)+ 
Fever* (range) (d) 8 t 4.3 (l-16) 6.5 rt 3.2 (l-10) 
Tachypnea (range) (d) 9.7 2 5.9 (2-20) 6.2 f 4.9 (l-16) 
Bacteremia n (%) 10 (50) 8 (67) 
Bilateral empyema n (%) l(5) 0 
WBCs (cells/mm3)* 19.205 2 7546 18.433 -t 10.081 
*Mean lr SD: +P 5 0.05. WBCs = white blood cell count; PCN-S = penicillin-susceptible S. pneumoniae; PCN-N = penicillin-nonsusceptible S. prteumoniae. 
method allowed classification of the strains into peni- 
cillin-susceptible, intermediate, and resistant pneumo- 
cocci, the PCN-S-PCN-N criterion was still used to stratify 
patients. 
The 6.04 Epi Info system (Centers for Disease Con- 
trol, Atlanta, Georgia) was used for statistical analysis. Out- 
come rates were compared by the Fisher’s exact test or 
chi-squared test, Yates-adjusted. Numerical data are pre- 
sented as an arithmetic mean C standard deviation (SD) 
and were compared by the Student’s t-test. A P-value of 
0.05 or less was considered significant. 
RESULTS 
Among 109 episodes of complicated pleural effusions or 
empyema that were analyzed, a bacterial pathogen was 
recovered in 45 cases (41%) with Spneumoniue account- 
ing for 32 (71%) of these isolates. Twenty strains (62%) 
were PCN-S and 12 (38%) PCN-N. The additional 13 iso- 
lates corresponded to Haemophilus influenzae % (n = 
5), Staphylococcus aureus (n = 4), Streptococccus pyo- 
genes (n = 3), and Pseudomonas aeruginosa (n = 1). 
Table 1 shows the clinical and epidemiologic fea- 
tures of patients with pleural empyema caused by PCN- 
S and PCN-N. The mean age t SD (mo) for PCN-S pleural 
empyema was 40.9 t 36.8 (range 2-156 mo), whereas 
patients with PCN-N pleural empyemas were significantly 
younger, 18.3 + 12.1 months (range 8-54 mo) (P < 0.05). 
Children with PCN-N infections had received previous 
antibiotic treatment more frequently than PCN-S (33% 
vs. 5%) (P = 0.05). 
No significant differences were seen in gender, under- 
lying disease, duration of tachypnea and fever, need of 
surgical treatment, presence of sepsis, bilateral disease, 
mean duration of therapy, or length of hospital stay. In all, 
59% of the children became bacteremic. 
Most of the children (87%) required chest tube place- 
ment. Mean 5 SD duration of the chest tube drainage 
was 7 2 1.4 and 9 + 2.2 days in PCN-S and PCN-N, 
respectively (P > 0.05). One patient in the PCN-S group 
was treated with thoracotomy and lobectomy. All chil- 
dren received empirical p-lactam antibiotics, with no dif- 
ferences in the class of antibiotic between PCN-S and 
PCN-N (Table 2). One child died with PCN-N infection, 
because of pulmonary bleeding. 
DISCUSSION 
Pleural empyema is one of the most common complica- 
tions of bacterial pneumonia.’ Indeed, the occurrence of 
pleural empyema in pneumococcal pneumonia in chil- 
dren has an incidence ranging from 2% to 13.8%,‘-3 
although reports are scarce.‘-’ Furthermore, S. pneumo- 
niae is the pathogen most frequently isolated.‘-’ Peni- 
cillin-resistant strains of S.pneumoniae have become a 
worrisome problem worldwide. The impact that these 
strains have had on the outcome of pleural empyema in 
children remains to be clarified.s-10 
Table 2. Comparative Outcome of 32 Children with Pleural Empyema Caused by Penicillin-Susceptible 
and Penicillin-Nonsusceptible Streptococcus pneumaniae 
Characteristic* PCN-S (n=20) PCN-N (n= 12) 
Empirical antibiotic treatment 
Ampicillin n (%) 7 (35) 
Cefuroxime n (%) 
4 (33) 
Ceftriaxone n (%) 
10 (50) 4 (33) 
Duration of treatment (d)+ 
3 (15) 4 (33) 
13.9 i 9.1 
Chest tube placement n (%) 
17 k 9.9 
Thoracotomy n (%) 
16 (80) 6 (50) 
Deaths n (%) 
1 (5) 0 
0 
Hospital stay (d)+ 
1 (5) 
14.5 + 6.3 18.8 2 8.4 
*P 2 0.05. +Mean IT SD. PCN-N = penicillin-nonsusceptible S. pneumoniae; PCN-S = penicillin-susceptible .S. pneumoniae, 
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The resistance rate found in the present study was 
similar to that reported by others in the United States.5 
This study also showed that children with complicated 
parapneumonic effusions caused by nonsusceptible iso- 
lates of S. pneumoniue were significantly younger than 
those infected with susceptible strains. In concordance 
with other studies,‘3,14 results showed that patients who 
had previously received antibiotic therapy were more 
likely to be infected by resistant strains. 
Friedland did not find any difference in the outcome 
of children with pneumococcal pneumonia caused by 
PCN-S in comparison with those with PCN-N infections.8 
The clinical features of patients in the present study also 
were similar in both groups. Furthermore, no differences 
in the bacteremia rates was observed between the 
groups. In contrast, Hardie and colleagues found that PCN- 
N parapneumonic effusions were significantly associated 
with a higher incidence of bacteremia than PCN-S effu- 
sions (100% vs. 29%, P < 0.05).5 
The most appropriate treatment of children with 
pleural empyema remains to be defined. In fact, most 
patients with empyema may be adequately treated with 
antibiotics and repeated pleural fluid aspirations or chest 
tube drainage.8-‘o Indeed, most of the children in this study 
had chest tube drainage (- 80%) without complications. 
Based on clinical studies8-r0 it appears that penicillin, 
ampicillin, cefuroxime, and ceftriaxone should be ade- 
quate to treat patients with pneumonia and pleural 
empyema caused by pneumococcal isolates for which 
the penicillin MICs are 2k/mL or less. Tan and colleagues 
evaluated 257 children with pneumococcal pneumonia 
in the USA.’ Among 73 children with pleural effusion& 
the outcome was the same for those with strains of PCN- 
S and of PCN-N. Similar data were obtained by Hardie 
and co-workers in 23 cases of children with peumococ- 
cal pleural empyema.5 Present data suggest that in 
patients with pleural empyema attributable to PCN-S or 
PCN-N, the therapy with standard p-lactam agents is effec- 
tive, however, the issue of optimal therapy will have to 
be continually reassessed. The children with infection 
caused by PCN-N had longer hospitalization, probably 
because they received more time of parenteral treatment 
with antibiotics. 
In summary, the outcome of children with S. pneu- 
moniae pleural empyema was not influenced by the 
penicillin susceptibility of the pneumococcus strains. 
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